Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.4.21.73 (urokinase-type plasminogen activator)
 10,685 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

From September 1992 to July 1997 56 cases (59 ears) of sudden deafness were treated with urokinase 20,000 unit a day for ten days. At the same time also using Papaverine hydrochloride, ATP and CoA. The effective rate of treatment was 86.44%. But for the control group of 48 cases treated with only Papavrine hydrochloride, ATP and CoA, the effective rate of treatment was 63.32%. There was significant difference between the two groups (P < 0.01). In addition, urokinase is safe and reliable in treating sudden deafness and has not be found any evident side-effect.
 ...
PMID:[Observation on large doses of urokinase in treatment of sudden deafness]. 1126 31